These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27058251)

  • 21. Rapid Review Summit: an overview and initiation of a research agenda.
    Polisena J; Garritty C; Umscheid CA; Kamel C; Samra K; Smith J; Vosilla A
    Syst Rev; 2015 Sep; 4():111. PubMed ID: 26407674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid evidence assessment: increasing the transparency of an emerging methodology.
    Varker T; Forbes D; Dell L; Weston A; Merlin T; Hodson S; O'Donnell M
    J Eval Clin Pract; 2015 Dec; 21(6):1199-204. PubMed ID: 26123092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methodological approaches in conducting overviews: current state in HTA agencies.
    Pieper D; Antoine SL; Morfeld JC; Mathes T; Eikermann M
    Res Synth Methods; 2014 Sep; 5(3):187-99. PubMed ID: 26052845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid Evidence Assessment of the Literature (REAL(©)): streamlining the systematic review process and creating utility for evidence-based health care.
    Crawford C; Boyd C; Jain S; Khorsan R; Jonas W
    BMC Res Notes; 2015 Nov; 8():631. PubMed ID: 26525982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments.
    Kaltenthaler E; Tappenden P; Paisley S
    Value Health; 2013; 16(5):830-6. PubMed ID: 23947977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid review programs to support health care and policy decision making: a descriptive analysis of processes and methods.
    Polisena J; Garritty C; Kamel C; Stevens A; Abou-Setta AM
    Syst Rev; 2015 Mar; 4():26. PubMed ID: 25874967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The main methodological aspects in Health Technology Assessment].
    Vallejos C; Bustos L; de la Puente C; Reveco R; Velásquez M; Zaror C
    Rev Med Chil; 2014 Jan; 142 Suppl 1():S16-21. PubMed ID: 24861175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration and practice of methods and processes of evidence-based rapid review on peer review of WHO EML application.
    Li Y; Yu J; Du L; Sun X; Kwong JS; Wu B; Hu Z; Lu J; Xu T; Zhang L
    J Evid Based Med; 2015 Nov; 8(4):222-8. PubMed ID: 26549534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative.
    Schreider J; Barrow C; Birchfield N; Dearfield K; Devlin D; Henry S; Kramer M; Schappelle S; Solomon K; Weed DL; Embry MR
    Toxicol Sci; 2010 Jul; 116(1):5-7. PubMed ID: 20363830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 10 years of NICE: still growing and still controversial.
    Littlejohns P; Garner S; Doyle N; Macbeth F; Barnett D; Longson C
    Lancet Oncol; 2009 Apr; 10(4):417-24. PubMed ID: 19341973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
    Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
    Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early assessment of medical technologies to inform product development and market access: a review of methods and applications.
    Ijzerman MJ; Steuten LM
    Appl Health Econ Health Policy; 2011 Sep; 9(5):331-47. PubMed ID: 21875163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How can the impact of Health Technology Assessment (HTA) in the Austrian healthcare system be assessed? Design of a conceptual framework].
    Schumacher I; Zechmeister I
    Gesundheitswesen; 2012 Apr; 74(4):257-65. PubMed ID: 21267815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of NICE technology appraisal in NHS rationing.
    Walker S; Palmer S; Sculpher M
    Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technology assessment in healthcare: a review and description of a "best practice" technology assessment process.
    Fernandez AM; Schrogie JJ; Wilson WW; Nash DB
    Best Pract Benchmarking Healthc; 1997; 2(6):240-53. PubMed ID: 9543920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [More care for a limited budget; a case for a better use of the efficiency criteria].
    Rutten FF; Brouwer WB
    Ned Tijdschr Geneeskd; 2002 Nov; 146(47):2254-8. PubMed ID: 12481524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Palliative Care Evidence Review Service (PaCERS): a knowledge transfer partnership.
    Mann M; Woodward A; Nelson A; Byrne A
    Health Res Policy Syst; 2019 Dec; 17(1):100. PubMed ID: 31842886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.